Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-033354

Chairman & CEO bought 2,160 shares at an average $10.86 ($23,465)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-14 Purchase : show line 1 in the form +1,680 $10.85 $18,228 3,227,139 D
2023-03-15 Purchase : show line 2 in the form +480 $10.91 $5,237 3,227,619 D
Open-market purchases · 2,160 sh · avg $10.86 · $23,465
Loading xslF345X03/tm239792-2_4seq1.xml…